Evidence map›Paper›PMID 36539611›Full record

ReviewNature reviews. Microbiology2023

Microbiota-mediated colonization resistance: mechanisms and regulation.

Gustavo Caballero-Flores, Joseph M Pickard, Gabriel Núñez

Abstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 279 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
279citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

279 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. From predicted bacteriocins to ecological function.Current research in microbial sciences · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

219 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gustavo Caballero-Flores *Department of Pathology and Rogel Cancer Center, The University of Michigan Medical School, Ann Arbor, MI, USA. gcflores@umich.edu.ORCID 0000-0002-0640-1521
Joseph M Pickard *Department of Pathology and Rogel Cancer Center, The University of Michigan Medical School, Ann Arbor, MI, USA.
Gabriel NúñezDepartment of Pathology and Rogel Cancer Center, The University of Michigan Medical School, Ann Arbor, MI, USA. gabriel.nunez@umich.edu.ORCID 0000-0002-6529-2695

Funding

Role of Immunity and the Microbiota in Enteropathogenic E. coli EradicationR01DK095782 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NUNEZ, GABRIEL · 2013 to 2022
$3.6M
Deciphering the pathogenesis of an enteric pathogen in neonatal and immunodeficient miceR00AI159620 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI CABALLERO FLORES, GUSTAVO · 2024 to 2025
$498k
Deciphering the pathogenesis of an enteric pathogen in neonatal and immunodeficient miceK99AI159620 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CABALLERO FLORES, GUSTAVO · 2022 to 2023
$185k
NIAID NIH HHS K99 AI159620NIAID NIH HHS R00 AI159620NIDDK NIH HHS R01 DK095782
6 · The paper itself

Abstract

A dense and diverse microbial community inhabits the gut and many epithelial surfaces. Referred to as the microbiota, it co-evolved with the host and is beneficial for many host physiological processes. A major function of these symbiotic microorganisms is protection against pathogen colonization and overgrowth of indigenous pathobionts. Dysbiosis of the normal microbial community increases the risk of pathogen infection and overgrowth of harmful pathobionts. The protective mechanisms conferred by the microbiota are complex and include competitive microbial-microbial interactions and induction of host immune responses. Pathogens, in turn, have evolved multiple strategies to subvert colonization resistance conferred by the microbiota. Understanding the mechanisms by which microbial symbionts limit pathogen colonization should guide the development of new therapeutic approaches to prevent or treat disease.

Indexed as

MicrobiotaImmunity

Identifiers

PMID36539611
PMCPMC10249723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.